ロード中...
The Use of Surrogate Endpoints in Regulating Medicines for Cardio-Renal Disease: Opinions of Stakeholders
AIM: There is discussion whether medicines can be authorized on the market based on evidence from surrogate endpoints. We assessed opinions of different stakeholders on this topic. METHODS: We conducted an online questionnaire that targeted various stakeholder groups (regulatory agencies, pharmaceut...
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4182561/ https://ncbi.nlm.nih.gov/pubmed/25268242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0108722 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|